Agenus
Price & Volume
Stats
See moreOpen | $4 |
Previous Close | $4.05 |
Day Range | $3.99-$4.10 |
52W Range | $4-$19.68 |
Market Cap | $87.3M |
Shares Short | 3M |
Financials
See moreRevenue (12 Mos) | $159.6M |
Revenue Growth (YoY) | -7.1% |
Gross Profit (12 Mos) | $82.6M |
Diluted EPS | -$11.14 |
News
See moreYahoo Finance • 2 months ago
GSK's Respiratory Syncytial Virus Vaccine Given Together With Shingles Shot Shows Non-Inferior Immune Response In Older Adults
Yahoo Finance • 3 months ago
Bristol Myers Squibb Terminates Cancer Drug Development Program With Agenus
Yahoo Finance • 9 months ago
Botensilimab/Balstilimab Breakthrough Data Presented at ASCO-GI Shows Unprecedented Tumor Shrinkage and Robust Biomarker Response in Prevalent Colorectal Cancer Population
Yahoo Finance • 10 months ago
2 Small Cap Stocks That Could Go Parabolic in 2024, According to Wall Street
About
CEO | Dr. Garo H. Armen Ph.D. |
Address | 3 Forbes Road, Lexington, MA, United States, 02421-7305 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 389 |
